The Next Generation Impactors (NGI) from MSP, a Division of TSI, are high-performance cascade impactors tailored for the Life Sciences industry, featuring seven stages for precise aerosol measurement.
For over 20 years, the NGI has been the industry standard, with 1,800+ units in use and integration into USP guidelines. Designed for the OINDP industry, the NGI delivers efficient and accurate in vitro aerodynamic particle size distribution (APSD) testing, supported by various automated and semi-automated add-ons to enhance workflow efficiency.
The NGI+ maintains the proven design while utilizing advanced materials, enabling a broader range of applications, chemicals, and drugs in aerosol research and development.
Products
Next Generation Impactor NGI
Next Generation Impactor NGI Plus
NGI and NGI Plus systems are foundational tools for measuring aerodynamic particle size distribution in inhalation products. Their precisely engineered stages, paired with standardized throats and accessories, support high-quality data generation under pharmacopeial methods.
Performance and Usability
Workflow Integration
Compliance Awareness
NGI-based testing aligns with guidance such as USP <601> and Ph. Eur. 2.9.18 for APSD. With appropriate method validation, documentation, and instrument maintenance, laboratories can produce robust, defensible data sets suitable for submissions and audits.
Use Cases
By combining NGI or NGI Plus with automation, environmental control, and structured data analysis, laboratories can achieve high productivity while maintaining strong data quality across the product lifecycle.